Jasperate

Regulation Crowdfunding offering on StartEngine

$100,000

of $100,000 goal

100.0% funded

About the offering

Our co-founder, Dr. Stephen Soloway is a renowned Rheumatologist who's double board certified in internal medicine and rheumatology. As a practicing physician, he's been treating trigger finger, arthritis, lupus, gout, osteoporosis, psoriasis, and other pain areas for 30 years. Some of his many accomplishments include Philadelphia Magazine Top Doctors since 2006 (Doctor with the most consecutive years on the list), Patient's Choice Award, Most Compassionate Doctor, Castle Connolly America's Top Doctors, Presidential Who's Who, and many others too numerous to list. In addition, Dr. Soloway was recently appointed by the Governor of New Jersey to the Board of Medical Examiners and has faculty appointments at the Medical College of Pennsylvania, Drexel University College of Medicine, and Rowan University School of Osteopathic Medicine. He is published in The New England Journal of Medicine, The Journal of Rheumatology, Clinical and Experimental Rheumatology, The Rheumatologist, and others. "Over the years I've seen and treated hundreds and hundreds of patients that suffer from trigger finger. We've developed this new innovative needle that we call the J-needle™ that can be used to reduce and sometimes completely eliminate the pain and suffering from this debilitating health concern. We're excited that we're now on the path to not only help our trigger finger patients, but also those that have back instrumentation and other ailments."

FAQ

How much has Jasperate raised?

Jasperate has raised $100,000 of a $100,000 goal.

Where is Jasperate's campaign listed?

The offering is listed on StartEngine, an SEC-registered Reg CF intermediary.

What are the terms of Jasperate's raise?

Common Stock, $510,000 cap, $1.00/share.

When does Jasperate's offering close?

The stated close date is Dec 28, 2017.